Altilix(®) Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study

The objective was to evaluate the effects of 6 months of supplementation with Altilix(®), containing chlorogenic acid and its derivatives, and luteolin and its derivatives, on cardiovascular risk and hepatic markers in subjects with metabolic syndrome (MetS). A randomized, double-blind, placebo-cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Castellino, Giuseppa, Nikolic, Dragana, Magán-Fernández, Antonio, Malfa, Giuseppe Antonio, Chianetta, Roberta, Patti, Angelo M., Amato, Antonella, Montalto, Giuseppe, Toth, Peter P., Banach, Maciej, Cicero, Arrigo F. G., Rizzo, Manfredi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893885/
https://www.ncbi.nlm.nih.gov/pubmed/31731527
http://dx.doi.org/10.3390/nu11112580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893885/
https://www.ncbi.nlm.nih.gov/pubmed/31731527
http://dx.doi.org/10.3390/nu11112580

Ejemplares similares